Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Millipore India Invests Rs 25 Lakh For Lab-On-Wheels Project

Millipore India has invested Rs 25 lakh for a lab-on-wheels project. The mobile lab is an initiative of Millipore India, Eppendorf and Micro Devices Metrohm. The state-of-the-art lab-on-wheels and is expected to visit college campuses where biotech, pharma and other science students across the country can have a real life experience on the laboratory practices.

The key objective of the lab is to showcase and demonstrate to students the latest lab equipment for applications like PCR, ion analysis, membrane filtration, protein research, chromatography etc. Through this institutions and students will not only get to see the latest sophisticated equipment but also get practical insights, ask questions, understand concepts.

Among the equipment on display and being demonstrated in the mobile lab is the Direct Q3, an international gold award winning pure and ultrapure water purification system designed specially for biotech/pharma/engineering colleges. Other life science products from Millipore include filtration units, general lab filtration devices, millex disposable syringe filters, centrifugals used in protein research.

Metrohm has on display the latest technologies and products for ion analysis, while Eppendorf has PCR equipment, equipment for cell manipulation, DNA amplification, pipettes, centrifuges etc.

(Ref : Chronicle Pharmabiz dated July 27, 2006)

ICMR, DBT Plans Revised Ethical Guidelines For Biomedical Research

Indian Council of Medical Research (ICMR) and the Department of Biotechnology (DBT) have undertaken a joint exercise to review the current 'Ethical Guidelines for Biomedical Research on Human Subjects' of the country. The revised version would specify before one can go for international collaborations in biomedical research. The move is in view of the increasing interest shown by foreign companies to outsource their clinical trials from India.

While India derives its potential from its large patient pool, ethnic diversity and hundreds of medical colleges, ICMR, DBT want to ensure that no international collaboration is taking place purely on the basis of commercial interest. The guidelines would talk about universal ethical requirement, community agreement and community consultation as part of introducing greater transparency in clinical trials. The revised guideline is to be ready by 2006 end.

According to sources, there is a need to protect the vulnerable population from being subjected to unethical clinical trials. Every stage of international collaboration, including the interest of the funding institution/agency should be monitored, experts feel. The caution is needed, as there are growing instances where the funding institution is really funded by others who have hidden interest in the particular clinical research programme.

Even as the guideline is getting ready, ICMR hopes to see the enactment of a law to control and regulate experimentation on human subjects. The draft bill is yet to get the final clearance from the law ministry and is expected to be introduced in the next session of the Parliament.

(Ref : Chronicle Pharmabiz dated June 29, 2006)






Other News

Bioengineered Tissue Repairs Damaged Knee Cartilages
Cordis' Third-Generation Coronary Stent Approved For Use In Europe
MV Hospital Completes Study of Low Cost LCT Device


Back | Back To Top | Previous | Next